The therapeutical efficiency of the newest extracorporal elimination procedure (Prometheus® treatment) in acute liver failure caused by intoxication;A legújabb extracorporalis eliminációs eljáras (Prometheus®-kezelés) terápiás hatékonysága mérgezés okozta akut májelégtelenségben

Orvosi Hetilap

Volumn 148, Issue 42, 2007, Pages 1981-1988

  Bakos, Ágnes ^a,c   Rikker, Csaba ^a   Tóvárosi, Szilveszter ^b   Kárteszi, Mihály ^a  

^a Peterfy Sandor Utcai Korhaz   (Hungary)

^b Fresenius Medical Care   (Hungary)

^c Fresenius Medical Care ^*  (Hungary)

Author keywords

Acute liver failure; Albumin bound toxins; Dialysis; Fractionated plasma separation and adsorption

Indexed keywords

AMMONIA; ANTITHROMBIN III; BILE ACID; BILIRUBIN; CREATININE; FIBRINOGEN; PARACETAMOL; PERMANGANATE POTASSIUM;

ADULT; AMANITA PHALLOIDES; ARTICLE; CASE REPORT; CONSERVATIVE TREATMENT; DETOXIFICATION; DRUG INTOXICATION; FEMALE; HUMAN; INTOXICATION; LIVER FAILURE; LIVER REGENERATION; LIVER TRANSPLANTATION; PATIENT SAFETY; STATISTICAL SIGNIFICANCE; THERAPY EFFECT; TREATMENT INDICATION;

EID: 35748969329     PISSN: 00306002     EISSN: 17886120     Source Type: Journal    
DOI: 10.1556/OH.2007.28171     Document Type: Article

References (25)

1. Kramer, L.: Acut liver failure. Wien Klin. Wochenschr., 2004, 116/3, 68-71.
2. Polson, J., Lee, W. M.: AASLD position paper: The management of acute liver failure. Hepatology, 2005, 41, 1179-1197.
3. van de Kerkhove, M. D., Hoekstra, R., Chamuleau, R. A. és mtsa: Clinical application of bioartificial liver support systems. Ann. Surg., 2004, 240, 216-230.
4. Schneider, A., Attaran, M., Meier P. N. és mtsai: Hepatocyte transplantation in an acute liver failure due to mushroom poisoning. Transplantation, 2006, 82, 1115-1116.
5. Aleem Khan, A., Parveen, N., Habeeb, M. A. és mtsa: Journey from hepatocyte transplantation to hepatic stem cell: A novel treatment strategy for liver disease. Indian J. Med. Res., 2006, 123, 601-614.
6. Denis, J., Opolon, P., Nusinovici, V. és mtsai: Treatment of encephalopathy during fulminant hepatic failure by haemodialysis with high permeability membrane. Gut, 1978, 19, 787-793.
7. O'Grady, J. G., Gimson, A. E. S., O'Brien, C. J. és mtsai: Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure. Gastroenterology, 1988, 94, 1186-1192.
8. Desmet, V. J., De Groote, J., Van Damme, B.: Acut hepatocellular failure. A study of 17 patients treated with exchange transfusion. Hum. Pathol., 1972, 3, 167, 182.
9. Desilvestro, G., Marson, P., Brandolse, R. és mtsai: A single institution's experience (1982-1999) with plasma-exchange therapy in patients with fulminant hepatic failure. Int. J. Artif. Org., 2000, 23, 454-461.
10. Stockmann, H., Hiemstra C. A., Marquet, R. L. és mtsa: Extracorporeal perfusion for the treatment of acute liver failure. Ann. Surg., 2000, 231, 460-470.
11. Ho, D. W. Y., Fan, S. T., Woo, Y. H. és mtsai: Selective plasma filtration for treatment of fulminant hepatic failure induced by D-galactosamine in a pig model. Gut., 2002, 50, 869-876.
12. Stange, J., Hassanein, T. I., Mehta, R. és mtsai: The molecular adsorbents recycling system as a liver support sytem based on albumin dialysis: a summary of preclinical investigations, prospective, randomised, controlled clinical trial, and clinical experience from 19 centers. Artif. Organs, 2002, 26, 103-110.
13. Heemann, U., Treichel, U., Loock, J. éss mtsai: Abumin dialysis in cirrhosis with superimposed acute liver injury: A prospective, controlled study. Hepatology, 2002, 36, 949-958.
14. Doria, C., Mandala, L., Scott, V. L. és mtsai: Fulminant hepatic failure bridged to liver transplantation with a molecular adsorbent recirculating system: A single-center experience. Dig. Dis. Sci., 2006, 51, 47-53.
15. Lahdenperä, A., Koivusalo, A. M., Vakkuri, A. és mtsai: Value of albumin dialysis therapy in severe liver insufficiency. Transplant. Int., 2005, 17, 717-723.
16. Sen, S., Felldin, M., Steiner, C. és mtsai: Albumin Dialysis and Molecular Adsorbents Recirculating System (MARS) for acut Wilson's Disease. Liver Transplantation, 2002, 8, 962-967.
17. Falkenhagen, D., Strobl, W., Vogt, G. és mtsai: Fractionated plasma separation system: a novel system for blood purification to remove albumin bound substances. Artif. Organs 1999, 23, 81-86.
18. Krause, A. Prometheus - a new extracorporeal liver support therapy. In Progress in the Treatment of Liver Diseases. Szerk.: Arroyo, V., Forns, X., Garcia-Pagán, J. C. és mtsa, Ars Medica, Barcelona, 2003, 437-443.
19. Rifai, K., Ernst, T., Kretschmer, U és mtsai: Prometheus® - a new extracorporeal system for the treatment of liver failure. J. Hepatol., 2003, 39, 984-990.
20. Rifai, K., Ernst, T., Kretschmer, U. és mtsai: Removal selectivity of Prometheus: A new extracorporeal liver support device. World J. Gastroenterol., 2006, 12, 940-944.
21. Rifai, K., Ernst, T., Kretschmer, U. és mtsai: The Prometheus device for extracorporeal support of combined liver and renal failure. Blood Purif, 2005, 23, 298-302.
22. Evenepoel, P., Laleman, W., Wilmer, A. és mtsai: Detoxifying capacity and kinetics of Prometheus - a new extracorporeal liver support system for the treatment of liver failure. Blood Purif, 2005, 23, 349-358.
23. Krisper, P., Haditsch, B., Stauber, R. és mtsai: In vivo quantification of liver dialysis: Comparison of albumin dialysis and fractionated plasma separation. J. of Hepatol., 2005, 43, 451-457.
24. Kramer, L., Bauer E., Schenk P. és mtsai: Successful treatment of refractory cerebral oedema in ecstasy/cocain-induced fulminant hepatic failure using a new high-efficacy liver detoxification device (FPSA-Prometheus). Wien Klin. Wochenschr., 2003, 115, 599-603.
25. Skwarek, A., Grodzicki, M., Nyckow, P. és mtsai: The use Prometheus FPSA system int the treatment of acute liver failure: Preliminary result. Transplant. Proc., 2006, 38, 209-211.